Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human BMPR1A Antibodies:
anti-Mouse (Murine) BMPR1A Antibodies:
anti-Rat (Rattus) BMPR1A Antibodies:
Go to our pre-filtered search.
Human Polyclonal BMPR1A Primary Antibody for IHC (p), WB - ABIN1882067
Waite, Eng: BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. in Human molecular genetics 2003
Show all 8 Pubmed References
Human Polyclonal BMPR1A Primary Antibody for CyTOF, FACS - ABIN4899788
Bleuming, Kodach, Garcia Leon, Richel, Peppelenbosch, Reitsma, Hardwick, van den Brink: Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. in The Journal of pathology 2006
Show all 6 Pubmed References
Human Polyclonal BMPR1A Primary Antibody for FACS, WB - ABIN4899787
Huse, Bakkebø, Oksvold, Forfang, Hilden, Stokke, Smeland, Myklebust: Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7. in European journal of immunology 2011
Show all 4 Pubmed References
Human Polyclonal BMPR1A Primary Antibody for IHC (p), WB - ABIN388732
Kan, Liu, McGuire, Berger, Awatramani, Dymecki, Kessler: Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. in Stem cells (Dayton, Ohio) 2009
Show all 3 Pubmed References
Human Monoclonal BMPR1A Primary Antibody for FACS, IHC - ABIN1724746
Nickel, Kotzsch, Sebald, Mueller: Purification, crystallization and preliminary data analysis of the ligand-receptor complex of the growth and differentiation factor 5 variant R57A (GDF5R57A) and BMP receptor IA (BRIA). in Acta crystallographica. Section F, Structural biology and crystallization communications 2011
Show all 2 Pubmed References
Human Monoclonal BMPR1A Primary Antibody for ICC, FACS - ABIN1724745
Nieminen, Abdel-Rahman, Ristimäki, Lappalainen, Lahermo, Mecklin, Järvinen, Peltomäki: BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. in Gastroenterology 2011
Show all 2 Pubmed References
Human Monoclonal BMPR1A Primary Antibody for CyTOF, ELISA - ABIN4284948
Bolander, Ji, Geris, Bloemen, Chai, Schrooten, Luyten: The combined mechanism of bone morphogenetic protein- and calcium phosphate-induced skeletal tissue formation by human periosteum derived cells. in European cells & materials 2016
Human Polyclonal BMPR1A Primary Antibody for FACS - ABIN4896654
He, Dong, Wang, Xu, Dai, Ma, Zhu: Bone morphogenetic protein receptor IB as a marker for enrichment of osteogenic precursor-like cells in human dermis. in Archives of dermatological research 2011
Human Polyclonal BMPR1A Primary Antibody for ELISA, WB - ABIN188547
Keller, Nickel, Zhang, Sebald, Mueller: Molecular recognition of BMP-2 and BMP receptor IA. in Nature structural & molecular biology 2004
Human Polyclonal BMPR1A Primary Antibody for FACS, WB - ABIN388737
Tominaga, Abe, Ueda, Goto, Nakahara, Murakami, Matsubara, Mima, Nagai, Araoka, Kishi, Fukushima, Jishage, Doi: Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathy. in The Journal of biological chemistry 2011
Show all 2 Pubmed References
both bone morphogenetic protein 2 (BMP2 (show BMP2 Antibodies)) and BMP6 (show BMP6 Antibodies) are proangiogenic in vitro and ex vivo and that the BMP type I receptors, activin receptor-like kinase 3 (ALK3) and ALK2 (show ACRV1 Antibodies), play crucial and distinct roles in this process.
BMPR1A and the ubiquitous isoform of BMPR1B differed in mode of translocation into the endoplasmic reticulum; and (ii) BMPR1A was N-glycosylated while BMPR1B was not, resulting in greater efficiency of processing and plasma membrane expression of BMPR1A.
Several germline variants in Hamartomatous Polyposis Syndrome genes were detected, among them three in ENG (show ENG Antibodies), two in BMPR1A, one in PTEN (show PTEN Antibodies), and one in SMAD4 (show SMAD4 Antibodies). Although some of the detected variants have been reported previously none could be definitely pathogenic or likely pathogenic.
The present study suggests that HNF-4alpha has a suppressive effect on hepcidin expression by inactivating the BMP pathway, specifically via BMPR1A, in HepG2 cells.
In solid ameloblastoma, positive correlations were observed between the stromal and parenchymal expression of BMP-2 (show BMP2 Antibodies) and between the stromal expression of BMP-2 (show BMP2 Antibodies) and BMP-4 (show BMP4 Antibodies), as well as between the stromal expression of BMPR-II (show BMPR2 Antibodies) and BMP-4 (show BMP4 Antibodies) and the stromal and parenchymal expression of BMPR-II (show BMPR2 Antibodies).
Data show that protein kinase (show CDK7 Antibodies) LKB1 (show STK11 Antibodies) physically interacts with BMP type I receptors and requires Smad7 (show SMAD7 Antibodies) protein to promote downregulation of the receptor.
BMPR1A(+) ASCs show an enhanced ability for adipogenesis in vitro, as shown by gene expression and histological staining.
Duplication of 10q22.3-q23.3 encompassing BMPR1A gene is associated with congenital heart disease, microcephaly, and mild intellectual disability
Authors analyzed human databases from TCGA and survival data from microarrays to confirm BMPR1a tumor promoting functions, and found that high BMPR1a gene expression correlates with decreased survival regardless of molecular breast cancer subtype.
About half of BMPR1A-related polyps displayed loss of heterozygosity, predominantly in the epithelial compartment, compatible with BMPR1A acting as a tumour suppressor gene.
These studies emphasize the pivotal role of BMPR1A in the determination of bone quality and mechanical integrity under physiological conditions, with different impact on femoral cortical and trabecular compartments.
loss of BMP signaling specifically in osteocytes dramatically increases bone mass presumably through simultaneous inhibition of RANKL (show TNFSF11 Antibodies) and SOST (show SOST Antibodies), leading to osteoclast inhibition and Wnt (show WNT2 Antibodies) activation together.
Data indicate the regulation of energy balance in BMPR1A-mediated appetite regulation in POMC (show POMC Antibodies) neurons.
findings suggest that GJA1 may be one of the downstream targets of BMPR1A signaling in osteoclasts that mediates osteoclast-osteoblast communication during bone remodeling.
deletion of BMPR1a in oncogenic astrocytes resulted in decreased proliferation, decreased invasion, decreased migration, and increased expression of stemness markers
different levels of expression and subsequent activation of Smad (show SMAD1 Antibodies) signaling differentially contribute each BMP type I receptor to BMP-Smad (show SMAD1 Antibodies) signaling and craniofacial development.
BMP signaling mediated by coordination of ALK2/ACVR1 (show ACRV1 Antibodies), ALK3/BMPR1A, and BMPR2 (show BMPR2 Antibodies) is an essential proangiogenic cue for retinal vessels.
Gonadotrope-specific Bmpr1a knockout animals developed normally and had reproductive organ weights comparable with those of controls. Knockouts were fertile, with normal serum gonadotropins and pituitary gonadotropin subunit mRNA expression. Cre-mediated recombination of the floxed Bmpr1a allele was efficient and specific, as indicated by PCR analysis of diverse tissues and isolated gonadotrope cells.
CK2.1 peptide drives chondrogenesis and cartilage formation without induction of chondrocyte hypertrophy by releasing CK2 (show CSNK2A1 Antibodies) from distinct sites at BMPRIa
These results suggest that Pax8 (show PAX8 Antibodies) maybe the downstream molecule of ALK3, it mediates the murine heart development via cellular senescence, which may serve as a mechanism that compensates for the cell loss via apoptosis in heart development.
Report temporal regulation of BMPR1a mRNA expression in the oocyte, granulosa and theca cells of developing preovulatory follicles in the pig.
ALK3 and ALK6 (show BMPR1B Antibodies) both contribute to the gene regulatory network that regulates dorso-ventral patterning.
Data show that USP15 (show USP15 Antibodies) enhances BMP-induced phosphorylation of SMAD1 (show SMAD1 Antibodies) by interacting with and deubiquitylating ALK3.
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.
, BMP type-1A receptor
, activin A receptor, type II-like kinase 3
, activin receptor-like kinase 3
, bone morphogenetic protein receptor type-1A
, serine/threonine-protein kinase receptor R5
, BMP-2/BMP-4 receptor
, bone morphogenetic protein 4 receptor
, bone morphogenetic protein receptor, type 1A
, BMP receptor 1
, bone morphogenic protein receptor 1
, protein kinase
, bone morphogenetic protein receptor IA
, bone morphogenetic protein receptor, type IA
, bone morphogenetic protein receptor type-1A-like
, BMP receptor
, bone morphogenetic protein receptor type IA